ArticleInternational journal of nanomedicine2023

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis.

Rong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.